Position in MEDP
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$683,170
-$4,461 QoQ
Shares Held
1,290
-9.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#360
of 689 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MEDP Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Compound Planning, Inc. holds $8,516,107 across 13 Diagnostics & Research names. MEDP ranks #6 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
4,209 | $2,110,224 | |
| 2 | DHR |
Danaher Corp /De/
|
6,338 | $1,207,261 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
1,575 | $829,142 | |
| 4 | DGX |
Quest Diagnostics Inc
|
3,830 | $811,768 | |
| 5 | NTRA |
Natera, Inc.
|
2,727 | $740,243 | |
| 6 | MEDP |
Medpace Holdings, Inc.
This page
|
1,290 | $683,170 | |
| 7 | A |
Agilent Technologies, Inc.
|
3,449 | $458,130 | |
| 8 | WAT |
Waters Corp /De/
|
1,102 | $413,293 |
All Filings in MEDP
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $683,170 | 1,290 | Shares | Other | 2026-08-04 | |
| 2026-03-31 | $687,631 | 1,432 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $743,624 | 1,324 | Shares | Sole | 2026-02-19 | |
| 2025-09-30 | $669,950 | 1,303 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $368,785 | 1,175 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $374,768 | 1,230 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $354,157 | 1,066 | Shares | Sole | 2025-01-17 | |
| No filing history on record for this holder in this stock. | ||||||